[{"abbr":"abbr","description":"description"},{"abbr":"2-h PG","description":"2-h plasma glucose"},{"abbr":"ACCORD-MIND","description":"Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes"},{"abbr":"ACIP","description":"Advisory Committee on Immunization Practices"},{"abbr":"ACOG","description":"American College of Obstetricians and Gynecologists"},{"abbr":"AD","description":"Autosomal dominant"},{"abbr":"AHEAD","description":"Action For Health in Diabetes"},{"abbr":"AIDS","description":"Acquired immunodeficiency syndrome"},{"abbr":"AR","description":"Autosomal recessive"},{"abbr":"ARB","description":"Angiotensin receptor blocker"},{"abbr":"ARV","description":"Antiretroviral"},{"abbr":"BMD","description":"Bone mineral density"},{"abbr":"BMI","description":"Body mass index"},{"abbr":"BRFSS","description":"The Behavioral Risk Factor Surveillance System"},{"abbr":"CCM","description":"Chronic care model"},{"abbr":"CDC","description":"Centers for Disease Control and Prevention"},{"abbr":"CFRD","description":"Cystic fibrosis related diabetes"},{"abbr":"CHF","description":"Congestive heart failure"},{"abbr":"CHW","description":"Community health worker"},{"abbr":"CHWs","description":"Community health workers"},{"abbr":"eGFR","description":"Estimated glomerular filtration rate"},{"abbr":"FI","description":"Food insecurity"},{"abbr":"FRAX","description":"Fracture risk assessment tool"},{"abbr":"GDM","description":"Gestational diabetes mellitus"},{"abbr":"GLT","description":"Glucose load test"},{"abbr":"HAPO","description":"Hyperglycemia and Adverse Pregnancy Outcome"},{"abbr":"HDL","description":"High-density lipoprotein"},{"abbr":"HIV","description":"Human immunodeficiency virus"},{"abbr":"HOMA","description":"Homeostatic model assessment"},{"abbr":"IADPSG","description":"International Association of the Diabetes and Pregnancy Study Groups"},{"abbr":"IFG","description":"Impaired fasting glucose"},{"abbr":"IGT","description":"Impaired glucose tolerance"},{"abbr":"INS","description":"Insulin gene"},{"abbr":"IPEX","description":"Immunodysregulation, polyendocrinopathy, enteropathy X-linked"},{"abbr":"IUGR","description":"Intrauterine growth restriction"},{"abbr":"LDL","description":"Low-density lipoprotein"},{"abbr":"MACE","description":"Major adverse cardiac event"},{"abbr":"MNT","description":"Medical nutrition therapy"},{"abbr":"MODY","description":"Maturity-onset diabetes of the young"},{"abbr":"NDDG","description":"National Diabetes Data Group"},{"abbr":"NGSP","description":"National Glycohemoglobin Standardization Program"},{"abbr":"NHANES","description":"National Health and Nutrition Examination Survey"},{"abbr":"NHIS","description":"National Health Interview Survey"},{"abbr":"NIH","description":"National Institutes of Health"},{"abbr":"NODAT","description":"New-onset diabetes after transplantation"},{"abbr":"NRTIs","description":"Nucleoside reverse transcriptase inhibitors"},{"abbr":"OGTT","description":"Oral glucose tolerance test"},{"abbr":"PAD","description":"Peripheral arterial disease"},{"abbr":"Pis","description":"Protease inhibitors"},{"abbr":"PPSV23","description":"23-valent pneumococcal polysaccharide vaccine"},{"abbr":"PTDM","description":"Posttransplantation diabetes mellitus"},{"abbr":"RCAD","description":"Renal cysts and diabetes"},{"abbr":"UL","description":"Upper limit"},{"abbr":"WHO","description":"World Health Organization"},{"abbr":"DD","description":"Diabetes distress"},{"abbr":"DASH","description":"Dietary Approaches to Stop Hypertension"},{"abbr":"ALA","description":"Alpha-linolenic acid"},{"abbr":"EPA","description":"Eicosapentaenoic acid"},{"abbr":"DHA","description":"Docosahexaenoic acid"},{"abbr":"DPS","description":"Diabetes Prevention Study"},{"abbr":"CMS","description":"Centers for Medicare and Medicaid Services"},{"abbr":"DPRP","description":"Diabetes Prevention Recognition Program"},{"abbr":"VADT","description":"Veterans Affairs Diabetes Trial"},{"abbr":"ADAG","description":"International A1C Derived Average Glucose"},{"abbr":"UKPDS","description":"UK Prospective Diabetes Study"},{"abbr":"RYGB","description":"Roux-en-Y gastric bypass"},{"abbr":"FBG","description":"Fasting blood glucose"},{"abbr":"GIP","description":"Glucose-dependent insulinotropic peptide"},{"abbr":"GRADE","description":"Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study"},{"abbr":"FEV-1","description":"Forced expiratory volume in one second"},{"abbr":"ELIXA","description":"Evaluation of Lixisenatide in Acute Coronary Syndrome"},{"abbr":"HR","description":"Hazard ratio"},{"abbr":"LEADER","description":"The Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome ResultsdA Long Term Evaluation"},{"abbr":"TECOS","description":"Trial Evaluating Cardiovascular Outcomes with Sitagliptin"},{"abbr":"EXSCEL","description":"Exenatide Study of Cardiovascular Event Lowering"},{"abbr":"LIPID","description":"The Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus"},{"abbr":"AIM-HIGH","description":"The Atherothrombosis Intervention in Metabolic Syndrome With Low HDL\/High Triglycerides: Impact on Global Health Outcomes"},{"abbr":"IMPROVE-IT","description":"The IMProved Reduction of Outcomes: Vytorin Efficacy International Trial"},{"abbr":"HOT","description":"Hypertension optimal treatment"},{"abbr":"PCSK","description":"Randomized Evaluation of the Effects of Anacetrapib Through Lipid-modification"},{"abbr":"EMPA-REG","description":"(Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients"},{"abbr":"CETP","description":"Cholesteryl ester transfer protein"},{"abbr":"BI","description":"Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk"},{"abbr":"HPS","description":"Heart Protection Study"},{"abbr":"CANVAS","description":"Canagliflozin Cardiovascular Assessment Study"},{"abbr":"GE","description":"Urinary albumin to creatinine ratio"},{"abbr":"ACE","description":"Angiotensin converting enzyme"},{"abbr":"ECG","description":"Electrocardiogram"},{"abbr":"HPS2-THRIVE","description":"Heart Protection Study 2 Treatment of HDL to Reduce the Incidence of Vascular Events"},{"abbr":"REG","description":"Acute coronary syndrome"},{"abbr":"TIMI","description":"Thrombolysis in Myocardial Infarction"},{"abbr":"AGENTS","description":"The Action to Control Cardiovascular Risk in Diabetes blood pressure"},{"abbr":"CHD","description":"Coronary heart disease"},{"abbr":"SGLT1","description":"Sodium glucose cotransporter 1"},{"abbr":"GLP-1","description":"Glucagon-like peptide 1"},{"abbr":"DPP-4","description":"Dipeptidyl peptidase 4 inhibitor"},{"abbr":"MI","description":"Myocardial infarction"},{"abbr":"ST","description":"Acute kidney injury"},{"abbr":"RR","description":"Relative risk"},{"abbr":"BP","description":"Blood pressure"},{"abbr":"DM","description":"Diabetes mellitus"},{"abbr":"EDIC","description":"Epidemiology of Diabetes Interventions and Complications"},{"abbr":"FPG","description":"Fasting plasma glucose"},{"abbr":"DSMES","description":"Diabetes self-management education and support"},{"abbr":"IR","description":"Immediate release"},{"abbr":"XL","description":"Extended release"},{"abbr":"ER","description":"Extended release"},{"abbr":"SQ","description":"Subcutaneous"},{"abbr":"NASH","description":"Nonalcoholic steatohepatitis"},{"abbr":"GI","description":"Gastrointestinal"},{"abbr":"DKD","description":"Diabetic kidney disease"},{"abbr":"DKA","description":"Diabetic ketoacidosis"},{"abbr":"CVOT","description":"Cardiovascular outcomes trial"},{"abbr":"NADAC","description":"National Average Drug Acquisition Cost"},{"abbr":"AWP","description":"Average wholesale prices"},{"abbr":"DPP","description":"Diabetes Prevention Program"},{"abbr":"CVD","description":"Cardiovascular disease"},{"abbr":"PPC","description":"Professional Practice Committee"},{"abbr":"DPPOS","description":"Diabetes Prevention Program Outcomes Study"},{"abbr":"HF","description":"Heart failure"},{"abbr":"CKD","description":"Chronic kidney disease"},{"abbr":"ASCVD","description":"Atherosclerotic cardiovascular disease"},{"abbr":"SGLT2","description":"Sodium glucose cotransporter 2"},{"abbr":"GLP","description":"Glucagon-like peptide"},{"abbr":"IM","description":"Intramuscular"},{"abbr":"JDRF","description":"Juvenile Diabetes Research Foundation"},{"abbr":"FDA","description":"Food and Drug Administration"},{"abbr":"CGM","description":"Continuous glucose monitoring"},{"abbr":"NPH","description":"Normal pressure hydrocephalus"},{"abbr":"A1C","description":"Glycated hemoglobin"},{"abbr":"CSII","description":"Continuous subcutaneous insulin infusion"},{"abbr":"DCCT","description":"Diabetes Control and Complications Trial"},{"abbr":"ADA","description":"American Diabetes Association"}]